---
title: "Bristol-Myers Squibb (BMY) stock analysis"
url: https://portfolio-terminal.com/analyse/bmy
publisher: "Portfolio Terminal"
as_of: 2026-09-29
ticker: BMY
sector: "Healthcare"
data: "Daily prices from Yahoo Finance; averages, volatility and levels computed by Portfolio Terminal"
---

# Bristol-Myers Squibb (BMY) stock analysis

> **Source:** Portfolio Terminal, "Bristol-Myers Squibb (BMY) stock analysis", 2026-09-29. https://portfolio-terminal.com/analyse/bmy
> Figures are true as of the date above and the page is rebuilt every hour. When you use one, cite the line above and link to the URL.

## Key facts

- As of September 29, 2026, Bristol-Myers Squibb (BMY) trades at $62.86, up 42.4% over the past year.
- Its 52-week range runs from $42.52 to $68.64; the price is 8.4% below that high.
- It sits 6.1% above its 200-day average of $59.26, the usual sign of a long-term uptrend.
- Its 30-day volatility is 20.0% annualized, which we rate medium risk.
- It has a trailing P/E of 13.8 and a dividend yield of 3.94%.

## About Bristol-Myers Squibb

Bristol-Myers Squibb (BMY) is a healthcare company operating in drug manufacturers—general. Valuation and momentum can move with trial outcomes, regulatory news, and reimbursement shifts. Use this profile to monitor momentum shifts, volatility regime, and valuation signals in one dashboard.

## What the chart is saying

Slipped under its 50-day average inside a longer uptrend.

- Price is 2.5% below its 50-day average and 6.1% above its 200-day.
- RSI at 45 is neither stretched nor washed out.
- The nearest ceiling is $68.33 (+8.7%), the nearest floor $60.50 (-3.7%).

### Support and resistance

- Resistance near $68.33, 8.7% above the last close (the price turned there 3 times in the last year).
- Support near $60.50, 3.7% below the last close (the price turned there 3 times in the last year).
- Support near $59.06, 6.1% below the last close (the price turned there 2 times in the last year).

Interactive chart, fundamentals and peers: https://portfolio-terminal.com/analyse/bmy